News
Can Rigetti Computing's Margin Recover After Second-Quarter Pressure?
Rigetti Computing’s RGTI second-quarter 2025 results gave investors a closer look at the pressures weighing on margins as it balances financial discipline with technology progress. Revenues slipped
Dollar General's Q2 Earnings Beat & Guidance Hike Signal Strong FY25
Dollar General Corporation DG reported second-quarter fiscal 2025 results, wherein both top and bottom lines beat the Zacks Consensus Estimate and increased year over year. The company delivered
Five Below Q2 Earnings & Sales Beat Estimates, FY25 View Raised
Five Below, Inc. FIVE reported impressive second-quarter fiscal 2025 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Also, net sales and earnings increased year over
HPQ's Q3 Earnings Match Estimates, Revenues Increase Y/Y
HP Inc. HPQ reported third-quarter fiscal 2025 earnings of 75 cents per share, in line with the Zacks Consensus Estimate. This compares to earnings of 84 cents per share a year ago. These figures
BASF to Showcase VALERAS & New Additive Solutions at K 2025
BASF SE BASFY is set to showcase its VALERAS portfolio’s journey at K 2025. BASFY will highlight how issues of plastic circularity, durability and carbon transparency have been addressed by its
Principal Financial Trades Above 200-Day SMA: Time to Hold PFG Stock?
Principal Financial Group, Inc. PFG has been trading above its 200-day simple moving average (SMA), signaling a short-term bullish trend. Its share price, as of Wednesday, was $80.84, down 12.1%
Otis to Elevate Connectivity on Singapore's Cross Island Line Phase 1
Otis Worldwide Corporation’s OTIS expanding global footprint continues to demonstrate its strong growth trajectory. The company is steadily increasing its market share worldwide, backed by its
Here's Why Investing in Zebra Technologies Stock Makes Sense
Zebra Technologies Corporation ZBRA is poised to gain from strength across its segments, acquired assets and shareholder-friendly moves.ZBRA currently carries a Zacks Rank #2 (Buy). In the past
Donaldson's Q4 Earnings Beat Estimates, Sales Increase Y/Y
Donaldson Company, Inc. DCI reported fourth-quarter fiscal 2025 (ended July 31, 2025) adjusted earnings of $1.03 per share, which beat the Zacks Consensus Estimate of $1.02. The bottom line
VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up
Veeva Systems, Inc. VEEV reported adjusted earnings per share (EPS) of $1.99 for the second quarter of fiscal 2026, which increased 22.8% from the year-ago figure of $1.62. Adjusted EPS beat the
RCL's Flywheel Effect Strengthens Bookings: Can the Momentum Hold?
Royal Caribbean Cruises Ltd. RCL is sharpening its focus on the commercial flywheel — a self-reinforcing model driven by loyalty, digital adoption and destination exclusivity — to underpin sustained
Howmet Faces Softness in Commercial Transportation Market: Recovery Ahead?
Howmet Aerospace Inc. HWM is witnessing persistent weakness in its commercial transportation market. After witnessing a 14% decline in first-quarter 2025, revenues from the commercial transportation
Intercontinental Exchange Trades Above 200-Day SMA: Time to Hold?
Intercontinental Exchange Inc. ICE has been trading above its 200-day simple moving average (SMA), signaling a short-term bullish trend. Its share price, as of Wednesday, was $177.30, down 6.3% from
5 Financial Transaction Stocks in Focus Amid Strong Cross-Border Volumes
Big Morning for Q2 Numbers: GDP +3.3%, Earnings Beats for Retailers
Thursday, August 28, 2025Pre-market futures have lots to digest this morning — not only following NVIDIA’s NVDA strong Q2 results after the closing bell last night (even if they came in slightly
NVIDIA Stock Could Pull Back in September, But Don’t Bet on It
There are reasons to believe that NVIDIA’s (NASDAQ: NVDA) stock price could pull back in September, but it’s not a possibility worth betting on. Although the approximately 100% stock price
Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?
Alnylam Pharmaceuticals ALNY is a commercial-stage company that currently markets four drugs. The company first received regulatory approval in 2018 for Onpattro to treat adult patients with
3 of Qualcomm’s Technical Indicators Are Suddenly Flashing Green
Shares of tech giant Qualcomm Inc. (NASDAQ: QCOM) closed just under $160 on Tuesday, continuing a rebound that has added more than 10% since the first week of August. That rally came after a



